| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CUP.12149 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcup.12149 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/cup.12149 | ||
| P698 | PubMed publication ID | 23581649 |
| P2093 | author name string | Alan Levy | |
| Goli Compoginis | |||
| Gene H. Kim | |||
| P2860 | cites work | Reviewing the somatic genetics of melanoma: from current to future analytical approaches | Q37976140 |
| Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management | Q50518821 | ||
| BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma | Q58024751 | ||
| Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia | Q79970137 | ||
| Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases | Q82719738 | ||
| Vemurafenib-induced neutrophilic panniculitis | Q84612687 | ||
| Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 | ||
| Inhibition of Mutated, Activated BRAF in Metastatic Melanoma | Q27860458 | ||
| Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside | Q37301003 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | panniculitis | Q780629 |
| metastatic melanoma | Q18975855 | ||
| P304 | page(s) | 667-669 | |
| P577 | publication date | 2013-04-15 | |
| P1433 | published in | Journal of Cutaneous Pathology | Q15749389 |
| P1476 | title | Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib | |
| P478 | volume | 40 |
| Q38919639 | BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities. |
| Q38370667 | Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature |
| Q48355954 | Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients |
| Q40155438 | Melanoma patients under vemurafenib: prospective follow-up of melanocytic lesions by digital dermoscopy |
| Q54372623 | Ponatinib-induced neutrophilic panniculitis |
| Q40086569 | Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation |
| Q37432850 | Systemic vasculitis associated with vemurafenib treatment: Case report and literature review |
| Q54378191 | Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption |
| Q54372609 | Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma |
Search more.